Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Xingqi Pharmaceutical(300573) the Revenue is 717.54 M (+14.51%);the EBIT is 253.46 M (+18.42%);the EPS is 0.62 (+16.2%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.72B14.51%
----
----
EBIT
0.25B18.42%
----
----
EPS
0.620416.20%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf